eSight, the Toronto, Canada-based vision-platform organization behind an advanced sight-enhancing glasses for the visually impaired, raised $10m in a debenture funding.
The backers were not disclosed.
The company intends to use the funds for new technology development and international expansion.
Led by Kevin Banderk, Chief Executive Officer, Charles Lim, Chief Technology Officer, Gregory Ogorek, COO and President, and Dr. Brian Mech, Chief Scientific Officer, eSight International is a vision-platform organization whose product portfolio includes eSight 3, electronic glasses with enhanced vision technology that are clinically proven to improve sight for people living with vision loss and help them regain independent mobility.
The company’s future product innovations for enterprise will combine wearable devices with apps and solutions.
It is registered with the FDA and EUDAMED, and is inspected by Health Canada.